Analyst Price Targets — ELV
Latest News for ELV
Beaconlight Capital LLC bought a new position in shares of Elevance Health, Inc. (NYSE: ELV) in the undefined quarter, according to its most recent Form 13F filing with the SEC. The fund bought 5,946 shares of the company's stock, valued at approximately $2,299,000. Elevance Health makes up about 0.8% of Beaconlight Capital LLC's
UNH outpaces ELV with stronger earnings prospects, improving Medicare profitability, greater upside and a more favorable risk-reward profile.
On August 25, 2026, we delve into the DCF analysis for Elevance Health Inc (ELV), a company that has shown impressive price performance recently, with a year-to
Barrow Hanley Mewhinney and Strauss LLC purchased a new stake in shares of Elevance Health, Inc. (NYSE: ELV) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 452,636 shares of the company's stock, valued at approximately $175,048,000. Barrow Hanley Mewhinney and
B. Metzler seel. Sohn and Co. AG purchased a new position in Elevance Health, Inc. (NYSE: ELV) in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 31,408 shares of the company's stock, valued at approximately $12,146,000. Other institutional investors have also
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.